I was trained primarily in child psychology and neuropsychology at the University of Michigan. After graduation, I worked at Children's Hospital of Michigan in Detroit. I then moved to Washington, DC, where I took a position at the National Institute of Mental Health. My laboratory was dedicated to understanding severe neuropsychiatric illnesses, including schizophrenia and related disorders, from cognitive, genetic, and neurobiological perspectives. I was Chief of the Neurocognitive Section for two decades. Since leaving the NIMH, my work has transitioned to the study of aging and dementia at Columbia University. I have published over 200 scientific articles. A complete list of these is available in PubMed under "author"/ Goldberg TE.
Over the course of my career, I have always seen patients for clinical evaluations with a focus on neuropsychological assessment. I'm continuing to do clinical work here at Columbia University Medical Center in my Faculty Practice.
Areas of Expertise / Conditions Treated
- Neuropsychology Evaluation
- Psychological Assessment
- Professor of Medical Psychology (in Psychiatry)
- NewYork-Presbyterian / Columbia University Irving Medical Center
Schedule an Appointment
- NYP Employee Plan
- Traditional Medicare
United Health Care
- Behavioral Health (Columbia University Employee Plan)
Credentials & Experience
Education & Training
- PhD, University of Michigan
- Fellowship: Children's Hospital of Michigan
Development of Novel Measures of Cognition & Function for Alzheimer’s Disease Prevention Trials PI: Dr. Terry Goldberg, PhD
This study aims to determine how effective different cognitive and functional tests commonly used in clinical trials really are in testing memory, executive function, and attention. Eligible participants are non-cognitively impaired, healthy adults (ages 60-85 years) who will be followed over the course of 12 months. Participants will receive either novel more experimental measures that are computerized or the older more established measures that involve paper and pencil tests. This study is funded by the NIA, a division of the NIH.
For more information, please contact Sophie Bell at 646-774-8691.
“Novel Cognitive and Functional Measure for Alzheimer’s Disease Prevention Trials” (Federal Gov)
SEPT 1 2018-MAY 31 2023